Table 2 Patients with surgical resection
BR (n = 31) | LA (n = 20) | Total (n = 51) | p-value | |
|---|---|---|---|---|
T stage, n (%) | ||||
pT1 | 1 (3) | 4 (20) | 5 (9.8) | 0.341 |
pT2 | 10 (32) | 5 (25) | 15 (29.4) | |
pT3 | 13 (42) | 7 (35) | 20 (39.2) | |
pT4 | 7 (23) | 4 (20) | 11 (21.6) | |
N stage, n (%) | ||||
pN0 | 7 (23) | 7 (35) | 14 (27.5) | 0.140 |
pN1 | 16 (51) | 12 (60) | 28 (54.9) | |
pN2 | 8 (26) | 1 (5) | 9 (17.6) | |
Retrieved lymph nodes, median (IQR) | 22 (11 - 30) | 17 (13 – 29) | 18 (12 - 29) | 0.609 |
Involved lymph nodes, median (IQR) | 3 (0 - 6) | 1 (0 - 2) | 2 (0 - 4) | 0.024 |
Duration of surgery, (min) median (IQR) | 480 (420 -540) | 451 (411-523) | 475 (415-525) | 0.576 |
Pancreatic specific complications, n (%) | ||||
Delayed gastric emptying | 10 (32.2) | 7 (35) | 17 (33.3) | 0.150 |
Pancreatic fistula | 1 (3.2) | 4 (20) | 5 (10) | 0.116 |
Hemorrhage | 4 (12.9) | 2 (10) | 6 (11.7) | 0.886 |
Bile leakage | 1 (3.2) | 1 (5) | 2 (3.9) | 1 |
Hospital stay, (days) median (IQR) | 12 (10 - 16) | 13 (10 - 14) | 12 (10 -14) | 0.968 |
Adjuvant chemotherapy, n (%) | 23 (85.2) | 13 (76.5) | 36 (81.8) | 0.690 |
Time from surgery until start adjuvant chemotherapy, (days) median (IQR) | 64 (40 - 303) | 60 (48 - 94) | 60 (48 - 98) | 0.657 |